HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Klintschar, M. Articles by Hoang-Vu, C. Search for Related Content PubMed PubMed Citation Articles by Klintschar, M. Articles by Hoang-Vu, C.

Fetal microchimerism in Hashimoto’s thyroiditis: a quantitative approach

¹ Institutes of Legal Medicine and ² Immunology, University Halle-Wittenberg, D06112 Halle/Saale, Germany, ³ Department of Child and Adolescent Psychiatry, Carl von Basedow Hospital, Merseburg, Germany, ⁴ University Clinic of Oral and Maxillo-Facial Surgery, University of Magdeburg, Magdeburg, Germany, ⁵ Institute of Pathology, Medical University Graz, A8036 Graz, Austria and ⁶ Experimental and Oncological Surgery Research Group, University Department of General, Visceral, and Vascular Surgery Department, University of Halle, Halle, Germany

(Correspondence should be addressed to M Klintschar; Email: michael.klintschar{at}medizin.uni-halle.de)

Objective: Fetal microchimerism (MCH) has been implicated in the etiology of autoimmune diseases such as autoimmune thyroiditis. The goal of the study was to reliably estimate the number of fetal engrafted cells and to further investigate factors influencing the development of MCH.

Methods: Quantitative real-time PCR amplification using Y-chromosome specific (DYS14) and autosomal (ß-globin) loci was performed on thyroid gland specimens. Furthermore, we compared the distribution of ABO and rhesus systems in mothers with and without blood MCH in relation to the blood groups of the children.

Results: MCH was detected in eight of 21 Hashimoto patients in a frequency range of 15 to 4900 male cells per 100 000 total cells (median 97 cells), but in none of 17 healthy thyroid glands. In a third group, consisting of 18 nodular goiters, only one sample was positive (182 male cells/100 000 total cells). No woman who had not had a prior pregnancy with a male fetus showed MCH. Mothers both with and without MCH showed the same rate of mother/child incompatibilities for the ABO and rhesus systems.

Conclusions: The percentage of microchimeric cells varies to a great extent in Hashimoto’s thyroiditis, and this phenomenon can occur in nodular goiter in rare instances, but it appears to be absent from normal thyroid glands. Nevertheless, the biological significance of MCH remains unclear. Moreover, we have concluded that the tested blood group systems (as opposed to their role in graft vs host disease after transplantations) have no effect on fetal MCH.

This article has been cited by other articles:

				D. W. Bianchi and N. M. Fisk Fetomaternal Cell Trafficking and the Stem Cell Debate: Gender Matters JAMA, April 4, 2007; 297(13): 1489 - 1491. [Full Text] [PDF]